Browse drugs

…erse events (headache 2.7%, itching 1.3%, others 6%) leading to aminaphtone discontinuation. NVC patterns in SSc patients treated with amin…

… monoclonal antibody inhibitor of EphrinB2. We hypothesize that MTX-474, via its action on EphrinB2, may promote myofibloblast reversio…

…s with CHD treated with bulevirtide were included in the study. Bulevirtide plasma levels, together with biochemical and virological marker…

…ed expression of Cyp1a1, a marker of AhR signalling.Conclusions Ficz, an AhR agonist, can alleviate skin fibrosis in BLM-induced SSc…

…armacologic interventions such as buprenorphine, methadone, and naltrexone, alongside integration of non-pharmacological strategies during…

…ance status (PS 0–1) are offered systematic anticancer therapy (SACT). This study investigated patterns of SACT use among patients w…

…y with axicabtagene ciloleucel (axi-cel). Bridging therapy with polatuzumab plus rituximab, followed by Axi-cel infusion after a standard l…

….91, 95% confidence interval 0.81 to 1.01; moderate certainty), vitamin D supplements (36 trials, 92 045 participants; 1.00, 0.95 to 1.06…

…of sexual intercourses (aOR 1.06 per 10 more, 95%CI 1.03-1.08). DoxyPEP was primarily used during groupsex (57.1%) and when attending c…

…Background The widespread adoption of cabotegravir (CAB)/rilpivirine (RPV) long-acting (LA) in clinical practice m…

…eview intends to explore the spectrum of commercially available DTx interventions for diabetes care and how they address the resear…

…ant in the US illicit drug supply, frequently co-occurring with fentanyl. This study examines trends in fentanyl-xylazine overdose death…